Lacosamide
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Lacosamide and local guidelines before prescribing.
Mechanism
Enhances slow inactivation of voltage-gated sodium channels.
Uses
Focal seizures (monotherapy or adjunct).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Dizziness, diplopia, headache, nausea, PR prolongation.
Interactions
Other sodium-channel blockers; PR-prolonging drugs.
Contraindications and cautions
AV block, severe cardiac disease
Monitoring
ECG if cardiac risk
Pregnancy and breastfeeding
Specialist advice
Renal and hepatic impairment
Reduce dose in severe renal or hepatic impairment
Overdose and reversal
Supportive
Special advice
ECG in cardiac conduction disease; avoid abrupt withdrawal.
More from the textbook: uses, cautions and other points
- Drugs that block sodium channels - carbamazepine , phenytoin , lamotrigine , lacosamide (epilepsy), lidocaine and other local anaesthetics, class I antiarrhythmics, tricyclic antidepressants in overdose.
Neurology: Anatomy, Physiology and Pharmacology - How they work - block sodium channels (carbamazepine, lamotrigine, phenytoin, lacosamide, oxcarbazepine), block calcium channels (ethosuximide - T-type, for absence; gabapentin, pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate …
Neurology: Anatomy, Physiology and Pharmacology - Focal seizures | Lamotrigine or levetiracetam . Alternatives: carbamazepine, oxcarbazepine, zonisamide, lacosamide
Neurology: Epilepsy - Lacosamide: Dizziness, PR prolongation (check ECG).
Neurology: Epilepsy
Where it is discussed in the book
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Neurology: Epilepsy (3 mentions)